We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$2.12B
AUM Growth
+$310M
Cap. Flow
+$172M
Cap. Flow %
8.15%
Top 10 Hldgs %
30.51%
Holding
1,206
New
135
Increased
542
Reduced
389
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 17.62%
2 Consumer Discretionary 8.62%
3 Financials 7.44%
4 Healthcare 6.97%
5 Communication Services 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIO
1126
Western Asset High Income Opportunity Fund
HIO
$335M
$100K ﹤0.01%
18,860
DCF
1127
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$96K ﹤0.01%
+10,000
New +$94.6K
PRVB
1128
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$93K ﹤0.01%
11,000
SIEN
1129
DELISTED
Sientra, Inc.
SIEN
$92K ﹤0.01%
1,150
RFIL icon
1130
RF Industries
RFIL
$135M
$90K ﹤0.01%
12,100
-1,000
-8% -$7.07K
FPL
1131
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$89K ﹤0.01%
15,071
+9
+0.1% +$51
IGD
1132
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$503M
$86K ﹤0.01%
14,450
AHT
1133
Ashford Hospitality Trust
AHT
$21M
$80K ﹤0.01%
+175
New +$63.5K
HIX
1134
Western Asset High Income Fund II
HIX
$352M
$79K ﹤0.01%
11,035
-2,000
-15% -$14.3K
ATRS
1135
DELISTED
Antares Pharma, Inc.
ATRS
$72K ﹤0.01%
+16,485
New +$67.2K
EGIO
1136
DELISTED
Edgio, Inc. Common Stock
EGIO
$66K ﹤0.01%
523
-225
-30% -$29.7K
AIXC
1137
AIxCrypto Holdings Inc
AIXC
$16.6M
$64K ﹤0.01%
64
GALT icon
1138
Galectin Therapeutics
GALT
$229M
$58K ﹤0.01%
17,998
MITT
1139
TPG Mortgage Investment Trust
MITT
$230M
$56K ﹤0.01%
4,371
-493
-10% -$6.15K
TRT
1140
Trio-Tech International
TRT
$93.3M
$52K ﹤0.01%
20,818
HUT
1141
Hut 8
HUT
$12.4B
$51K ﹤0.01%
+2,300
New +$44.3K
EFOI icon
1142
Energy Focus
EFOI
$18.3M
$48K ﹤0.01%
1,714
MTCR
1143
DELISTED
Metacrine, Inc. Common Stock
MTCR
$48K ﹤0.01%
+12,700
New +$52.5K
AQST icon
1144
Aquestive Therapeutics
AQST
$462M
$42K ﹤0.01%
10,500
+500
+5% +$2K
MUX icon
1145
McEwen Inc
MUX
$1.03B
$28K ﹤0.01%
2,020
TRVN
1146
DELISTED
Trevena, Inc.
TRVN
$24K ﹤0.01%
23
GERN icon
1147
Geron
GERN
$911M
$18K ﹤0.01%
13,100
-6,000
-31% -$8.73K
NBRV
1148
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$14K ﹤0.01%
+400
New +$14.9K
NMTR
1149
DELISTED
9 Meters Biopharma
NMTR
$11K ﹤0.01%
500
GAB.RT
1150
DELISTED
The Gabelli Equity Trust Inc. Rights (expiring July 14, 2021)
GAB.RT
$5K ﹤0.01%
+42,910
New +$4.99K

Similar funds

Wedbush Securities's Q2 2021 Portfolio in Review

As of Q2 2021, Wedbush Securities held 1,206 positions worth $2.12B, up 17% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Wedbush Securities deployed $172M of net new capital in Q2 2021, opening 135 new positions and adding to 542 existing holdings. Its largest new stake was Pacer Trendpilot US Bond ETF: 159,495 shares worth $4.42M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $3.52M trimmed.

  • Wedbush Securities's largest Q2 2021 buy was Pacer Trendpilot US Bond ETF: 159,495 shares worth $4.42M.
  • Wedbush Securities added most to Apple in Q2 2021, an estimated $21.1M increase.
  • Wedbush Securities's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $3.52M.
  • Wedbush Securities fully exited PGIM Short Duration High Yield Opportunities Fund in Q2 2021, selling an estimated $4.14M.
  • Wedbush Securities's ten largest holdings make up 31% of its $2.12B portfolio in Q2 2021.
  • Wedbush Securities opened 135 new positions and closed 50 in Q2 2021.
  • Wedbush Securities's portfolio value rose 17% quarter-over-quarter to $2.12B.

Based on Wedbush Securities's 13F filing for Q2 2021, filed 27 Jul 2021.